Navigation Links
Finesse Solutions Launches Next Generation G3Lab Universal SmartControllers to Enhance Productivity in Bench Scale Cell Culture and Fermentation
Date:6/5/2013

SANTA CLARA, Calif., June 5, 2013 /PRNewswire/ -- Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of its new G3Lab Universal™ SmartControllers for upstream cell culture and fermentation.

These SmartControllers are designed to not only work with stirred-tank glass vessels from most major manufacturers, but also stirred-tank single-use vessels and rockers.  They offer single-use sensors for pH and dissolved oxygen as well as traditional electrochemical ones and standard sensors for temperature and foam/level.  They also have a significant amount of spare input/output capacity for peripheral devices such as pumps or scales for more sophisticated perfusion processes.

Each G3Lab Universal controller leverages Finesse's new SmartParts components.  The utility tower has a standard set of four peristaltic SmartPumps, a SmartMotor driver and SmartTransmitters for TruFluor or electrochemical sensors.  Up to six gases can be controlled using SmartMFCs in a compact gas manifold.  The new packaging also further reduces the footprint of each unit in order optimize lab bench utilitization.

Dr. Barbara Paldus , CEO of Finesse stated that "G3Lab Universal SmartControllers represent a paradigm shift in building a research or process development laboratory, because each SmartController represents a bio-processing point rather than a specific bioreactor vessel.  The laboratory can be easily re-configured for different process platforms in different groupings with a minimal capital investment.  Because all the SmartControllers can be networked into a single-use data historian, they represent a step forward in asset optimization and R&D data management."   

About Finesse Solutions, Inc

California-based Finesse Solutions, Inc, has established a proven record in providing turn-key, scalable solutions for single-use upstream bio-processing.  The Finesse product platform includes an extensive portfolio of novel disposable sensors, modular configure-to-order automation hardware, and intelligent software that can harmonize global bio-process information and technology transfer.   Finesse also offers a complete set of services including startup, commissioning, and validation for rapid and reliable deployment of single-use equipment into cGMP manufacturing applications. For more information, please visit us at www.finesse.com.


'/>"/>
SOURCE Finesse Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Finesse Solutions Turns to HiveMind Marketing to Revitalize Website
2. MEDIFIRST SOLUTIONS, INC. To Exhibit At The Orlando International Beauty Show
3. Specialty Operations Solutions joins The WorkingBuildings Companies
4. Royalty Pharma Recommends Elan Shareholders vote "NO" on each of the Elan Resolutions at the Elan extraordinary general meeting
5. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
6. BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
7. Medifirst Solutions, Inc. Announces Update To Shareholders
8. Life Line Screening and MCM Solutions for Better Health Announce New Partnership
9. Pi2 Solutions 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia
10. Specific Technologies Bloodstream Infection Identification Solutions Discussed at the American Society for Microbiology Conference by Award Lecturer Christine Ginocchio
11. Hyland Software Forms Multi-Disciplinary Clinical Leadership Team to Augment Healthcare Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb 23, 2017 Research and Markets ... Analysis and Strategies - 2016" report to their offering. ... The latest research ... pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer and ...
(Date:2/23/2017)... 2017 AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ... and commercialization of innovative therapies for the treatment ... release fourth quarter and yearly financial results after ... management will host an investment-community conference call at ... on March 2 nd 2017 to discuss ...
(Date:2/23/2017)... , February 23, 2017 ... from increasing caseload for varicose veins in their body. ... globe are prompting the adoption of endovenous laser therapy ... global endovenous laser therapy market, published by ... of lifestyle choices and consequences of obesity have collectively ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 23, 2017 , ... Rare Disease Report®, which is the ... Rare Disease Day events, hosted by the Rare Disease Legislative Advocates (RDLA) on ... weekly e-newsletter and quarterly publication, will be conducting interviews with patients and advocates ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing ... generations converge and explore the world from different perspectives. By providing a place ... to gain understanding, increase empathy, and find greater happiness. , "Our approach ...
(Date:2/23/2017)... RI (PRWEB) , ... February 23, 2017 , ... ... today a new partnership with the Rhode Island Consortium for Autism Research and ... an opportunity for children with autism spectrum disorder (ASD) to see films in ...
(Date:2/23/2017)... York (PRWEB) , ... February 23, 2017 , ... Curemark, ... the safety and efficacy of CM-AT in children aged 3-8 with Autism, is now ... clinical sites already enrolling children across the United States. , “There are currently ...
Breaking Medicine News(10 mins):